These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11381274)

  • 1. A matter of perspective.
    Malik P
    Can J Cardiol; 2001 May; 17(5):527-8. PubMed ID: 11381274
    [No Abstract]   [Full Text] [Related]  

  • 2. CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy.
    Jahrsdörfer B; Weiner GJ
    Curr Opin Investig Drugs; 2003 Jun; 4(6):686-90. PubMed ID: 12901226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulators and some aspects of their clinical use].
    Khaitov RM; Pinegin BV
    Klin Med (Mosk); 1996; 74(8):7-12. PubMed ID: 9036219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunocorrective therapy in eye pathology].
    Oftalmol Zh; 1987; (7):385-7. PubMed ID: 3441330
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of metastasis.
    Dallal RM; Lotze MT
    Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vaccines and adjuvants for allergen-specific immunotherapy.
    Crameri R; Rhyner C
    Curr Opin Immunol; 2006 Dec; 18(6):761-8. PubMed ID: 17010585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?].
    Taube C; Buhl R
    Dtsch Med Wochenschr; 2008 Apr; 133(14):727-32. PubMed ID: 18363195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in anticancer responses.
    Whelan M
    Curr Opin Mol Ther; 2004 Feb; 6(1):8-9. PubMed ID: 15011775
    [No Abstract]   [Full Text] [Related]  

  • 9. [Principles of immunologic therapy. Elements for a new strategy].
    Bach JF
    Rev Prat; 1980 Mar; 30(15):895-8, 903-5. PubMed ID: 7375788
    [No Abstract]   [Full Text] [Related]  

  • 10. Future immunotherapies in multiple sclerosis.
    Blevins G; Martin R
    Semin Neurol; 2003 Jun; 23(2):147-58. PubMed ID: 12894380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current immunotherapy treatment].
    Serrou B
    Soins; 1980 May; 25(9):17-26. PubMed ID: 6900395
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives in immunotherapy.
    Zierhut M; Schlote T; Stübiger N; Stiemer R; Kötter I
    Dev Ophthalmol; 1999; 30():231-44. PubMed ID: 10627927
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular Immunotherapy and the Role of Imaging.
    Zupančič E; Fayad ZA; Mulder WJM
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):e167-e171. PubMed ID: 29070539
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of mycobacterial adjuvant-based agents for immunotherapy of cancer.
    Grange JM; Bottasso O; Stanford CA; Stanford JL
    Vaccine; 2008 Sep; 26(39):4984-90. PubMed ID: 18625281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for cardiovascular disease.
    Martini E; Stirparo GG; Kallikourdis M
    J Leukoc Biol; 2018 Mar; 103(3):493-500. PubMed ID: 29345361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical immunotherapy: what's new.
    Sauder DN; Mofid MZ
    Dermatol Clin; 2005 Apr; 23(2):245-58. PubMed ID: 15837154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic approaches for renal cancer.
    Pizza G; de Vinci C; Viza D
    Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
    [No Abstract]   [Full Text] [Related]  

  • 18. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
    Rhee Fv
    Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvants for specific immunotherapy past, present, future.
    Drachenberg KJ
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):275-9; discussion 280-1. PubMed ID: 11487886
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer.
    Seya T; Akazawa T; Uehori J; Matsumoto M; Azuma I; Toyoshima K
    Anticancer Res; 2003; 23(6a):4369-76. PubMed ID: 14666723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.